Hacker News

an hour ago by ecedeno

Moderna has a public development pipeline. It shows they are working on, among other things, an HIV vaccine and vaccines/therapies for multiple types of cancer.

https://www.modernatx.com/pipeline

11 minutes ago by est31

Plus a flu vaccine:

> mRNA vaccines [...] generate a much stronger immune response than responses that are generated to the protein in a normal flu vaccine [...]

> One limitation of the current flu vaccines is that they take about six months to develop, meaning scientists must choose which strains they think will be prevalent in the next flu season ā€” even before the current one is over. So by the time the vaccines are ready for distribution, a different strain may have emerged as the better target.

> An mRNA flu vaccine, on the other hand, can be developed in about a month or so, giving researchers much more time to determine which strains to protect against.

https://www.washingtonpost.com/health/2021/04/11/mrna-flu-sh...

The flu vaccine seems to me to have a better chance of working than an HIV vaccine because we have been trying for decades to come up with one for HIV, without any success at all. I'm not saying that their attempts won't work either, but it's more of a bet than a flu vaccine. An iterative improvement on the existing flu vaccines would still be very helpful.

31 minutes ago by undefined

[deleted]

2 hours ago by ProjectArcturis

There are a lot of folks excited about mRNA as a "programming language" for the body. And it kind of is, but it's more complicated than that. The critical thing is that mRNA is extremely immunogenic -- that is, it provokes a strong immune response. Makes sense, since evolutionarily when we had little particles delivering RNA strands to our cells, they we viruses.

So, that's great for vaccine production. Not so great for other diseases. Cystic fibrosis, for example, the body fails to make one specific protein. We (probably) can't just program it to produce that protein, because it would also train the immune system to target that protein. The best non-vaccine targets are probably cancer, where you want to get the immune system revved up against a tumor.

a few seconds ago by gfodor

Depending on your defect, CF can either under-produce CFTR, produce deficient CFTR, or produce no CFTR. Iā€™d imagine each of these scenarios has different viability for mRNA theraputics.

5 minutes ago by JPLeRouzic

> We (probably) can't just program it to produce that protein, because it would also train the immune system to target that protein.

I am not a scientist but my understanding is that the immune system targets only what it is trained against. It doesn't target anything which is non-self without being trained beforehand.

IMO if it was otherwise there would be no need for vaccine.

So I think that it is quite feasible to make a cell to produce a new protein, for example Zolgensma [0] works that way: It creates a new gene (hence a new protein) to replace a deficient one.

[0] https://en.wikipedia.org/wiki/Onasemnogene_abeparvovec

an hour ago by CorrectHorseBat

I thought they solved that by replacing U by 1-methyl-3'-pseudouridylyl in mRNA vaccines? I can imagine it's not great for vaccines either, you want the immune system attack the spike the mRNA codes for, not destroy the mRNA before it can do it's thing.

https://berthub.eu/articles/posts/reverse-engineering-source...

2 hours ago by im3w1l

What about hiv?

2 hours ago by simcop2387

HIV is a virus, so it would seem to be a good candidate for mRNA since you'd want to make it generate an aggressive and early response to the virus. I can't even guess though what challenges would arise given that HIV likes to target the immune system itself.

an hour ago by unnouinceput

3 hours ago by jcims

Many cancers exhibit immunosuppressive qualities that allow them to co-exist in a healthy immune system. It seems possible that mRNA-based therapies could be used to interfere with those mechanisms (eg binding to PD-L1, etc).

The delivery mechanism for the mRNA appears to be the primary innovation and I wonder if it would be possible to target it at specific cells. In the cancer context if you could differentially target the mRNA delivery to cancerous tissue, the 'payload' could be more generally cytotoxic but only affect tissue proximate to cancer cells.

This seems like it's on the order of CRISPR for potential to change the landscape of medicine in the next 50 years.

2 hours ago by hirenj

I was thinking about this very subject this morning, and I realised the mRNA stuff actually isnā€™t the exciting part.

Itā€™s the packaging in lipid particles that is much more interesting. We can get away with this approach for vaccines because we (largely) donā€™t care where we deliver the payload to, just as long as we get mRNA to a cell where it can make the protein. Not sure about current formulation, but I read most LNPs end up in the liver from circulation.

The next level of tech is targeting the particles, and then it gets as tricky as other contemporary techs, because you want your targeting mechanism on the prticles to be something resembling a receptor ligand (protein/carbohydrate).

Manufacturing of those (and putting them on a lipid particle) is still a slog. If we figure out nice ways to do that (without reasonable purity) then it doesnā€™t matter what is in the LNP (e.g put gold particles inside cancer targeting particles and zap your cancer cells dead).

2 hours ago by DanielBMarkham

I agree. It's easy to overstate things, but over the next several decades I could easily see a computational personalized approach to fighting cancer: read the unique immunosuppressive markers, sort out what's tractable and what's not, then deliver a mRNA payload for that particular cancer for that particular person.

For the incredibly small amount that I know, it looks like a game changer. (Like everything else, though, there's a long road from theory to practice. Implementation is going be very tough)

2 hours ago by umanwizard

Possibly naive question: if you can differentially target any particular thing to cancer cells specifically, why not just deliver poison to kill the cells directly? I.e. chemotherapy but without any of the nasty side effects.

3 hours ago by GEBBL

I am so excited for the prospect of mRNA treatments, especially in the field of auto immune conditions like multiple sclerosis. Those scientists are heroes.

3 hours ago by pseudosudoer

I haven't read anything related to treating autoimmune diseases with mRNA, that would be quite exciting. Do you happen to have a reference for this?

I have Ulcerative Colitis, which is a form of an autoimmune disease. A vaccine as a cure would be a game changer.

3 hours ago by usrusr

How would the treating of auto immune work? In my understanding you can trick the immune system into putting yet anther protein on the "kill on sight" list, by forcing the protein's mRNA blueprints into the production pipeline of some cells and... waiting, assuming that the immune system does its thing. So far so good. But isn't an autoimmune problem an entry on the "kill list" that shouldn't be there? I understand how we can append to that list (through a fascinatingly elaborate stack of indirections), but how can we revoke an entry?

Not questioning, just willing to learn.

2 hours ago by maxerickson

They target signaling mechanisms that the immune system uses.

I think I don't understand it very well, but it seems one approach is to have the vaccine cause cells involved in an auto immune disorder to put a bunch of 'friend' markers on their surface. So the technology is that they can trigger protein expression and the medical approach is to get cells to express proteins that lessen immune activity against the cell.

2 hours ago by jonlucc

I work in a pharma company, and I have been working with the animal model they use for this paper regularly for the past 4 or 5 years. I am not an mRNA therapy expert by any means, so I'll only comment on the results from the MOG35-55 and PLP EAE models.

They have good disease induction in their control groups, their targeted mRNA therapy shows pretty remarkable efficacy, and they show they can diversify a little bit with respect to the target.

These models are a little too "furry test tube" for me for this application. They work by injecting an antigen, either a short version of the myelin oligodendrocyte glycoprotein (MOG) peptide or the myelin proteolipid protein (PLP). The mouse makes antibodies against that antigen, and those antibodies also attack those antigens in their natural environments, leading to demyelination in the CNS. Well their mRNA for the MOG model makes more MOG peptide, giving the antibodies another target so they don't cause demyelination. In the human condition, there are multiple antibodies against multiple targets, so I'm not sure this is as relevant as they're suggesting, unless I'm missing something. I do want to add that this paper has a ton of work in it, and it looks pretty high quality as far as I can tell.

None of this is to say there's no value here, I'm just not sure what target they would make an mRNA for to treat human MS based on this paper or how they'd identify and test that target to get FDA approval to move into trials.

3 hours ago by mvanaltvorst

Are there any online resources where I could learn more about what mRNA treatments could theoretically cure? Take Hashimoto's disease for example, a disease where your thyroid gland slowly gets destroyed by your immune system. If I understand correctly, mRNA could stop your thyroid gland from getting destroyed in the first place, but it cannot regenerate the thyroid gland if it has already been destroyed. Is that correct?

2 hours ago by henron

My mental model is that in the next decade or so mRNA treatments could be effective if a disease can be treated through the expression of a small number of proteins. These proteins could either have a direct function or stimulate an immune response. I think your example works.

2 hours ago by mvanaltvorst

What kind of proteins are important when you're looking at the immune system? Is there a protein that can attach to thyroid gland cells and signals to the body that it isn't a threat? Or is there some sort of memory of the immune system with non-threat cells, that mRNA could overwrite? I'm not a biologist, I'd love to read more about these specific inner workings without dissecting a whole undergraduate biology book.

3 hours ago by jcims

If that's possible, curing type 1 diabetes would be on the horizon as well. There's some evidence that people with t1d have latent beta cells that could be reactivated to restore normal(ish?) insulin response. That would be incredible.

2 hours ago by vallard

I really really hope so.

an hour ago by subpixel

Tick-borne diseases are not all similar but many of them are very, very nasty and Lyme Disease is not the worst of them.

Iā€™d love for my kids to be able to play in the weeds and woods with abandon the way I did.

2 hours ago by rossmohax

Why this article is so Rossi centered? Did he play key role in mRNA breakthrough?

2 hours ago by khendron

Because the article is about him and the company he (co)founded.

an hour ago by caturopath

Because he/his company is the subject of the article?

The headline doesn't make that all that clear, but everything about the article seems to.

21 minutes ago by createmyname

and rossi thinks this way:

"Immortality is not something that that will ever be achievable"

well, noted.

2 hours ago by coldcode

mRNA seems almost like a biological programming language; if you can determine how to build a protein that triggers the body's immune system to attack something you want to destroy it's just a matter of design and testing. I wonder if you could build a real language that you could use to design a sequence and automate the testing.

40 minutes ago by arrosenberg

You could, but keep in mind mRNA occurs in 3D and thermodynamic and kinetic forces play a huge role in biochemistry, so itā€™s quite a bit more complicated than your average program.

2 hours ago by undefined

[deleted]

Daily digest email

Get a daily email with the the top stories from Hacker News. No spam, unsubscribe at any time.